UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052347
Receipt number R000059760
Scientific Title A retrospective study on oral rehydration solution intake during preoperative oral rehydration therapy
Date of disclosure of the study information 2023/09/29
Last modified on 2024/12/09 16:11:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study on oral rehydration solution intake during preoperative oral rehydration therapy

Acronym

A retrospective study on oral rehydration solution intake during preoperative oral rehydration therapy

Scientific Title

A retrospective study on oral rehydration solution intake during preoperative oral rehydration therapy

Scientific Title:Acronym

A retrospective study on oral rehydration solution intake during preoperative oral rehydration therapy

Region

Japan


Condition

Condition

Surgery in general

Classification by specialty

Surgery in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigate preoperative ORS intake from medical information of cases undergoing PO-ORT.
For cases of inadequate intake, we will clarify the cause based on the patient's background and consider improvement measures.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Factors leading to insufficient preoperative oral rehydration intake

Key secondary outcomes

Relationship between preoperative oral rehydration intake and intraoperative blood pressure reduction


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Subjects aged over 20
(2)Patients scheduled for surgery
(3)Subjects with American Society of Anesthesiologists physical status (ASA-PS) I or II
(4)Patients drunk OS-1

Key exclusion criteria

(1)Subjects with dementia or Parkinson's disease

Target sample size

2500


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Taniguchi

Organization

Saiseikai Yokohamashi Tobu Hospital

Division name

Department of Patient Support Center

Zip code

230-8765

Address

3-6-1 Shimosueyoshi Tsurumiku Yokohamashi Kanagawa

TEL

045-576-3000

Email

taniguchihideki@outlook.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Taniguchi

Organization

Saiseikai Yokohamashi Tobu Hospital

Division name

Department of Patient Support Center

Zip code

230-8765

Address

3-6-1 Shimosueyoshi Tsurumiku Yokohamashi Kanagawa

TEL

045-576-3000

Homepage URL


Email

taniguchihideki@outlook.jp


Sponsor or person

Institute

Saiseikai Yokohamashi Tobu Hospital

Institute

Department

Personal name

Hideki Taniguchi


Funding Source

Organization

Otsuka Pharmaceutical Factory, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kanagawa Cancer Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saiseikai Yokohamashi Tobu Hospital Institutional Review Board

Address

3-6-1 Shimosueyoshi Tsurumiku Yokohamashi Kanagawa

Tel

045-576-3000

Email

k_harita@tobu.saiseikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

済生会横浜市東部病院(神奈川県)
Saiseikai Yokohamashi Tobu Hosptital, Kanagawa

神奈川県立がんセンター(神奈川県)
Kanagawa Cancer Center


Other administrative information

Date of disclosure of the study information

2023 Year 09 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 09 Month 28 Day

Date of IRB


Anticipated trial start date

2023 Year 09 Month 28 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2024 Year 12 Month 30 Day

Date analysis concluded



Other

Other related information

retrospective study


Management information

Registered date

2023 Year 09 Month 28 Day

Last modified on

2024 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059760